Literature DB >> 16926830

beta(2)-Microglobulin amyloidosis caused spinal cord compression in a long-term haemodialysis patient.

J-R Vignes1, S Eimer, R Dupuy, E Donois, D Liguoro.   

Abstract

STUDY
DESIGN: A case report of cervical myelopathy caused by epidural beta (2)-microglobulin (beta2m) amyloid deposits in a 50-year-old woman with haemodialysis treatment.
OBJECTIVE: Long-term haemodialysis in patients with end-stage renal disease leads to several complications based on beta2m deposits, which can affect, in the cervical spine, the intervertebral disk, and in rare cases, they may compress the spinal cord and nerves. The objective of this report is to describe the clinical and radiological follow-up preceding the indispensable surgical excision of an amyloid mass in a 50-year-old woman with haemodialysis treatment. Long-term postoperative cervicalgia owing to subcondylian bone cyst-associated atlanto-occipital instability is also described and discussed.
SETTING: Department of Neurosurgery A, Hop Pellegrin, Bordeaux, France. CASE REPORT: We present a clinical case of a patient with spinal cord compression. The patient was treated by surgical excision of an amyloid mass subsequent to a C2-C3 laminectomy. The patient experienced clinical improvement with a regression of all of her neurological symptoms. Histological findings confirm the diagnosis of beta2m amyloid deposition. However, 5 years after surgery the subcondylian bone cysts were still observed and atlanto-occipital instability required her to wear a minerva.
CONCLUSION: Our case report confirms that surgical excision of beta2m epidural deposits is necessary and relevant when neurological prognosis is discussed, and that pain is still the major symptom of disease evolution. The use of high-flux synthetic membranes could decrease the beta2m blood level and early renal graft is the only method to prevent such complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926830     DOI: 10.1038/sj.sc.3101969

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  8 in total

1.  Hemodialysis-related upper cervical extradural amyloidoma presenting with intractable radiculopathy.

Authors:  Yasuhiro Takeshima; Masashi Kotsugi; Young-Su Park; Hiroyuki Nakase
Journal:  Eur Spine J       Date:  2011-11-25       Impact factor: 3.134

2.  Spinal cord compression in dialysis-related upper cervical amyloidoma - a case report.

Authors:  Pietro Domenico Giorgi; Maria Ludovica Pallotta; Simona Legrenzi; Giuseppe Rosario Schirò
Journal:  Spinal Cord Ser Cases       Date:  2021-05-25

3.  Surgical Outcome for Hemodialysis-Related Upper Cervical Lesions.

Authors:  Keiji Wada; Yasuaki Murata; Yoshiharu Kato
Journal:  Asian Spine J       Date:  2015-09-22

4.  Differential diagnosis of tumoral lesions in the spinal canal in patients undergoing hemodialysis.

Authors:  Keiji Wada; Yasuaki Murata; Yoshiharu Kato
Journal:  Asian Spine J       Date:  2015-04-15

5.  The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients.

Authors:  Tsung-Ting Tsai; Arun-Kumar Kaliya-Perumal; Chang-Chyi Jenq; Chi-Chien Niu; Natalie Yi-Ju Ho; Tung-Ying Lee; Po-Liang Lai
Journal:  J Orthop Surg Res       Date:  2017-12-21       Impact factor: 2.359

6.  Postoperative Complications and Survival Rate in Hemodialysis-Dependent Patients Undergoing Cervical Spine Surgery.

Authors:  Keiji Wada; Ryo Tamaki; Tomohisa Inoue; Kenji Hagiwara; Ken Okazaki
Journal:  Spine Surg Relat Res       Date:  2021-12-14

Review 7.  Cervical amyloidoma of transthyretin type: a case report and review of literature.

Authors:  Matthew H MacLennan; André le Roux
Journal:  BMC Geriatr       Date:  2022-09-15       Impact factor: 4.070

8.  Surgical Treatment for Atlanto-Occipital Subluxation due to Destructive Spondyloarthropathy in a Patient Undergoing Long-Term Hemodialysis.

Authors:  Keiji Wada; Yasuaki Murata; Yoshiharu Kato
Journal:  Asian Spine J       Date:  2015-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.